The CDC GUIDELINE announcement will not make that much difference.
The contents of the guideline are already well knows as CDC employees have been giving presentations showing what will be in the guidelines form many months. I am sure that Cellestis sales people are already using these presentations to promote the use of In Tube. Thus there will be nothing new in the guidelines so no price spike.
- Forums
- ASX - By Stock
- big sell orders
The CDC GUIDELINE announcement will not make that much...
Featured News
Add CST (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.005(6.67%) |
Mkt cap ! $19.35M |
Open | High | Low | Value | Volume |
7.5¢ | 8.1¢ | 7.5¢ | $22.67K | 295.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7000 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 103803 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7000 | 0.076 |
2 | 369863 | 0.075 |
1 | 10000 | 0.073 |
1 | 15000 | 0.072 |
1 | 29850 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 103803 | 1 |
0.089 | 21486 | 1 |
0.090 | 35000 | 1 |
0.095 | 37500 | 1 |
0.098 | 50000 | 1 |
Last trade - 14.08pm 16/07/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |